<DOC>
	<DOCNO>NCT00002167</DOCNO>
	<brief_summary>To determine objective tumor response remission rate AIDS-related Kaposi 's sarcoma ( KS ) follow single dose tin ethyl etiopurpurin ( SnET2 ) follow photodynamic therapy ( PDT ) . To determine systemic local toxicity , morbidity safety profile SnET2-PDT .</brief_summary>
	<brief_title>Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi 's Sarcoma Study Summary .</brief_title>
	<detailed_description>All patient receive single dose SnET2 randomize receive either PDT light treatment light treatment ( control group ) . Patients assess prior 4 , 12 24 week follow treatment , follow 7 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Tin etiopurpurin</mesh_term>
	<criteria>Inclusion Criteria Patients must : Documentation least one biopsyconfirmed KS lesion . A minimum 4 36 KS lesion . All eligible lesion must bidimensionally measurable , treatable surface ( noncontact ) light illumination , &lt; = 40 mm diameter long bidimensional axis . ACTG disease state T ( 0 ) L ( 0 ) ( 1 ) S ( 0 ) ( 1 ) . Life expectancy great 6 month . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Active opportunistic infection condition except thrush herpes simplex virus infection . Advanced KS tumor stage include presence tumor associate edema ulceration , extensive oral KS , KS nonnodal viscera . Hematopoietic dysfunction . Coagulation dysfunction . Hepatic dysfunction . Renal dysfunction . Cardiovascular dysfunction Presence significant coronary artery disease require current treatment myocardial infarction . Pulmonary dysfunction . Sepsis . Known disorder lipoprotein metabolism clearance . Patients follow prior condition exclude : History allergic hypersensitivity reaction light , egg protein egg yolk , history porphyria , systemic lupus erythematosus xeroderma pigmentosum . Excluded within 7 day therapy : Hematopoietic dysfunction . Coagulation dysfunction . Hepatic dysfunction . Renal dysfunction . Excluded within 3 month therapy : Pulmonary dysfunction . Excluded within 6 month therapy : Myocardial infarction . Prior Medication : Excluded : Intralesional chemotherapy within past 12 week . Systemic chemotherapy investigational drug within past 4 week . Prior Treatment : Excluded within 3 month prior therapy : Local cryotherapy surgery study lesion . Systemic topical photodynamic therapy agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1999</verification_date>
	<keyword>Skin Neoplasms</keyword>
	<keyword>Sarcoma , Kaposi</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Photochemotherapy</keyword>
	<keyword>tin etiopurpurin</keyword>
	<keyword>Radiation-Sensitizing Agents</keyword>
</DOC>